Tirzepatide is a once-weekly injection that mimics two gut hormones, GLP-1 and GIP, both released after you eat. By activating both receptors, it improves insulin response, slows stomach emptying, and reduces appetite. It is sold as Mounjaro for type 2 diabetes and Zepbound for weight management and sleep apnea, and in trials it has produced some of the largest weight reductions seen with a medication.
What Tirzepatide Is
According to Cleveland Clinic, tirzepatide is a dual agonist, meaning it mimics both GLP-1 and GIP. The FDA has approved it for type 2 diabetes in adults and children 10 and older, for weight management, and for moderate to severe obstructive sleep apnea in adults with obesity. It comes only as a weekly injection, not as a pill.
How GLP-1 and GIP Work Together
Both hormones are triggered by eating and increase insulin production, as Cleveland Clinic describes. Semaglutide, the ingredient in Ozempic and Wegovy, mimics only GLP-1. Tirzepatide covers both, and shared effects include better blood sugar and insulin sensitivity, slower stomach emptying, less appetite, and reduced body fat.
If you want the foundation first, our article on how GLP-1 and insulin work together explains the first half of this partnership. Cleveland Clinic’s pharmacist expert adds that tirzepatide typically shows greater glucose lowering and weight loss, although individual responses vary.
What the Research Shows
The SURMOUNT-1 trial enrolled 2,539 adults with overweight or obesity and without diabetes. Over 72 weeks, alongside lifestyle support, average weight change was:
- 15.0% loss at the 5 mg dose
- 19.5% loss at the 10 mg dose
- 20.9% loss at the 15 mg dose
- 3.1% loss with placebo
In people with type 2 diabetes, the SURPASS-2 trial found tirzepatide lowered A1C more than semaglutide 1 mg over 40 weeks, with significantly greater weight loss. These are averages, and your own results may differ, so set expectations with your provider rather than comparing yourself to a headline number.
Dosing and How Tirzepatide Is Taken
The Zepbound FDA label describes a gradual climb. Treatment starts at 2.5 mg weekly for four weeks, which is for starting only, then moves to 5 mg. Further increases come in 2.5 mg steps, each after at least four more weeks, up to a maximum of 15 mg weekly.
The slow pace exists to ease your digestive system into treatment. If you miss a dose, the label says to take it as soon as possible within four days, and to skip it after that.
Side Effects of Dual-Action Treatment
The most common side effects are digestive. In adult weight loss trials listed on the FDA label, nausea occurred in 25% to 29% of people on tirzepatide versus 8% on placebo, diarrhea in 19% to 23% versus 8%, vomiting in 8% to 13% versus 2%, and constipation in 11% to 17% versus 5%. Cleveland Clinic notes the effects also include heartburn, abdominal pain, fatigue, and headaches. In SURMOUNT-1, digestive events were described as mild to moderate and mostly occurred during dose escalation, and 4.3% to 7.1% of people on tirzepatide stopped treatment because of side effects, compared with 2.6% on placebo.
Tirzepatide carries a boxed warning for thyroid C-cell tumors, and the label lists warnings including pancreatitis, gallbladder disease, and kidney injury from dehydration. Severe gastroparesis and pregnancy are reasons to avoid it, according to Cleveland Clinic. Our article on the role of GLP-1 in long-term weight maintenance explains why staying consistent matters.
Is Dual Action Right for You?
Only a provider can match a medication to your health history. Cleveland Clinic’s expert stresses that these are long-term medications, and that lifestyle habits such as regular activity and nutritious eating remain part of the plan. This article is for general education and is not a substitute for personalized medical advice.
Frequently Asked Questions
Is Tirzepatide a GLP-1 Medication?
Partly. It activates the GLP-1 receptor, and also the GIP receptor, which is why it is called a dual agonist.
Is Tirzepatide Stronger Than Semaglutide?
In trials, tirzepatide has typically lowered A1C and body weight more, but individual responses and side effects vary.
Does Tirzepatide Come as a Pill?
No. According to Cleveland Clinic, tirzepatide is available only as a once-weekly injection.